Annexon Biosciences's total assets for Q2 2025 were $264.57M, a decrease of -12.69% from the previous quarter. ANNX total liabilities were $65.56M for the fiscal quarter, a 10.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.